All News

The tumors of patients with non-small cell lung and renal cell cancer shrunk following treatment with pegilodecakin plus immunotherapy.

Reading, writing, art, music... CURE recently asked its social media audience to share the creative outlets and activities that have helped them on their cancer journey. Here are some of their responses – in the hopes of helping others find a new hobby of their own.

Like many people who receive a cancer diagnosis, one survivor questions the reason.

From Matthew Knowles revealing a male breast cancer and BRCA2 diagnosis to a sarcoma survivor donating thousands of toys in lieu of birthday presents, here’s what is making headlines in the cancer space this week.

Knowing your family history is the first preventative step any woman can take to avoid a diagnosis of ovarian cancer.

Phase 3 trial findings showed that treatment with Lynparza delayed disease progression by about four months compared with newer hormonal agents in pre-treated patients with metastatic castration-resistant prostate cancer and faulty DNA repair genes.

Every cancer survivor has days when negative thoughts take over. Why not use visualization of video games to get rid of the self-defeating ideas?

Here’s a look at what’s inside our 2019 Immunotherapy special issue.

An early clinical trial participant likens his journey into the unknown to a space mission.

"I don’t have cancer, but here I am. This is my life. This is my reality. I am BRCA positive."

A man who received chimeric antigen receptor-T cell therapy shares his firsthand account.

CURE spoke with an expert on how patients can better advocate for themselves when it comes to genetic testing and its follow-up.

Let music keep you company during and after cancer.

Here are the top five CURE stories for September 2019.

Although there is much to learn about the intricacies of how the immune system interacts with cancer, advances are occurring rapidly as immunotherapy for cancer has exploded with myriad ongoing clinical trials and newer drugs coming on line constantly.

Readers of CURE share the ways that cancer has changed their lives.

In this special issue of CURE®, we take a walk through history, from revisiting the major medical milestones of immunotherapy to reviewing how far it has come in cancer treatment.

A male breast cancer survivor discovers that looking ahead may be good for our health.

Ovarian Cancer Research Alliance (OCRA) supports women and their families going through an ovarian cancer diagnosis, while also funding the research that will one day lead to its prevention.

The Food and Drug Administration expanded its approval of Cologuard, an at-home non-invasive colorectal cancer screening test, to include use among average-risk individuals aged 45 and older.

For Blood Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

A two-time cancer survivor discusses her recently-discovered pancreatic cysts.

From a freezer failure that lost the stem cells of some patients with cancer to a documentary about one of the pioneers of immunotherapy, here’s what is making headlines in the cancer space this week.

Immunotherapy medications have been a wonderful addition to the arsenal of cancer therapeutics. Their use has revolutionized the treatment of many cancers and offers new hope to patients. However, these upsides do not come without downsides.

The four-drug regimen of Darzalex in combination with Velcade, Thalomid and dexamethasone has been approved for the treatment of newly diagnosed patients with multiple myeloma who are eligible for autologous stem cell transplant.

Influenza season is almost here. In an effort to prevent the spread of the viral infection, some doctors recommend an annual vaccine. In this post, one survivor shares what happened when she shared details about her breast cancer and lymphedema experience before receiving the vaccine.

Cutting-edge treatment is not out of reach, thanks to a little guidance from the Cancer Research Institute.

Topical immunotherapy may help prevent the second most common type of skin cancer in the United States, according to study findings published in JCI Insight.